Tanaka, Yasuhito <br/><br/>
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection.  [electronic resource] 

 -  Journal of gastroenterology  Aug 2004 
 - 769-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0944-1174 
<br/><br/><label>Standard No.: </label>10.1007/s00535-003-1387-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amino Acid Sequence--genetics<br/>Antiviral Agents--therapeutic use<br/>Chromosome Deletion<br/>DNA Mutational Analysis<br/>DNA, Viral--blood<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Resistance, Viral--genetics<br/>Female<br/>Hepacivirus--drug effects<br/>Hepatitis B Surface Antigens--genetics<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Lamivudine--therapeutic use<br/>Liver Function Tests<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Prognosis<br/>Proportional Hazards Models<br/>Protein Precursors--genetics<br/>Regression Analysis